Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.

Casdozokitug, in combination with atezolizumab/bevacizumab, final data demonstrate durability of response and improvement in depth of response ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Antivenoms often need to be transported in cold storage, however, India’s rural parts lack the supporting infrastructure and ...

In return for these rights, ArriVent will pay Lepu a one-time down payment and near-term milestone payments amounting to ...

Danish team led by Nobel Prize winner David Baker has designed synthetic molecules that protect mice against cobra toxins.

Charting, Price Performance, News & Related Contracts.

Dr. Imbert brings 25 years of strategic clinical to commercial-stage manufacturing and drug development experienceSOUTH SAN FRANCISCO, Calif., ...

USANA Health Sciences, Inc., a global leader in cellular nutrition, is proud to announce that Dr. Kathryn Armstrong, Ph.D., ...

Dr. Imbert brings 25 years of strategic clinical to commercial-stage manufacturing and drug development experience SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, ...

ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology platform, and a protein engineering ...